Holen Sie sich die Stockscreener-App
11.66
6.12%
-0.76
Vorhandelsmarkt:
11.80
0.14
+1.20%
Schlusskurs vom Vortag:
$12.42
Offen:
$12.435
24-Stunden-Volumen:
3.18M
Relative Volume:
1.62
Marktkapitalisierung:
$793.99M
Einnahmen:
$2.73B
Nettoeinkommen (Verlust:
$-1.13B
KGV:
-0.6998
EPS:
-16.6622
Netto-Cashflow:
$-83.00M
1W Leistung:
-3.00%
1M Leistung:
-32.41%
6M Leistung:
-57.40%
1J Leistung:
-57.89%
1-Tages-Spanne:
$11.58
$12.80
1-Wochen-Bereich:
$11.19
$12.85
52-Wochen-Spanne:
$10.86
$38.99
Quidelortho Corp Stock (QDEL) Company Profile
Firmenname
Quidelortho Corp
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
11.66 | 793.99M | 2.73B | -1.13B | -83.00M | -16.66 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corp Aktie (QDEL) Neueste Nachrichten
QuidelOrtho Q1 2026 slides: revenue falls 13%, respiratory weakness pressures margins - Investing.com Nigeria
QuidelOrtho Q1 Earnings Call Highlights - Yahoo Finance
QuidelOrtho Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
QuidelOrtho (QDEL) Q1 2026 Earnings Transcript - AOL.com
QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
QuidelOrtho (NASDAQ: QDEL) posts Q1 2026 loss as revenue declines 11% - Stock Titan
Earnings call transcript: QuidelOrtho Q1 2026 results miss expectations - Investing.com
Earnings Flash (QDEL) QuidelOrtho Corporation Reports Q1 Revenue $619.8M, vs. FactSet Est of $665.2M - marketscreener.com
QuidelOrtho (NASDAQ:QDEL) Misses Q1 CY2026 Revenue Estimates - StockStory
QuidelOrtho Corp (NASDAQ:QDEL) Misses Q1 2026 Estimates, Shares Slide 2.7% - ChartMill
QuidelOrtho: Q1 Earnings Snapshot - kens5.com
Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q1 Adjusted Loss $0.04 per Share - marketscreener.com
A weak respiratory season hit QuidelOrtho as its 2026 targets fell - Stock Titan
QuidelOrtho (NASDAQ: QDEL) trims 2026 outlook after Q1 revenue and margin decline - Stock Titan
QuidelOrtho Reports First Quarter 2026 Financial Results - PR Newswire
symbol__ Stock Quote Price and Forecast - CNN
QuidelOrtho (QDEL) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
QuidelOrtho Corp. Hits New 52-Week Low at $10.86 Amid Ongoing Struggles - Markets Mojo
Earnings preview: QuidelOrtho (QDEL) Q1 earnings expected to decline - MSN
LEX Diagnostics acquired by QuidelOrtho Corporation for $100m six years after launch - Cambridge Independent
Earnings Preview: QuidelOrtho to Report Financial Results Post-market on May 05 - Moomoo
QuidelOrtho (QDEL) price target decreased by 18.10% to 29.38 - MSN
Vanguard holds 4,088,168 shares of QuidelOrtho (NASDAQ: QDEL) - Stock Titan
QuidelOrtho (QDEL) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline - Yahoo Finance
QuidelOrtho to discontinue Savanna platform development - MSN
Estuary Capital Management LP's QuidelOrtho Corp(QDEL) Holding History - GuruFocus
Why is QuidelOrtho (QDEL) down 24.5% since last earnings report? - MSN
QuidelOrtho Corp (QDEL) Shares Surge 6.1% -- What GF Score of 60 Tells Investors - GuruFocus
[ARS] QuidelOrtho Corp SEC Filing - Stock Titan
[DEF 14A] QuidelOrtho Corp Definitive Proxy Statement - Stock Titan
TTP Group sells LEX Diagnostics to QuidelOrtho to scale PCR tech - MSN
QuidelOrtho (QDEL) drops 20% after-hours on Wednesday—what's going on? - MSN
Why diagnostics names CareDx and QuidelOrtho just diverged - MSN
QuidelOrtho completes $100m acquisition of LEX Diagnostics from TTP - Business Weekly
QuidelOrtho, MIND Technology, Southern First Bancshares and other big stocks moving lower in Thursday's pre-market session - MSN
QuidelOrtho Corp. Opens with 5.51% Gain Amid Ongoing Financial Challenges - Markets Mojo
QuidelOrtho (QDEL) COO reports RSU vesting and tax share withholding - Stock Titan
QuidelOrtho(QDEL.US) 10% Shareholder Sells US$5.72 Million in Common Stock - 富途牛牛
QuidelOrtho (NASDAQ:QDEL) Reaches New 12-Month LowWhat's Next? - MarketBeat
Understanding and Addressing Syphilis Trends – and What’s Being Missed - The Malaysian Reserve
QuidelOrtho stock sinks to 52-week lowhere's why - MSN
Understanding and Addressing Syphilis Trendsand What's Being Missed – Company Announcement - Financial Times
QuidelOrtho (NASDAQ:QDEL) Shares Down 7.1%Here's What Happened - MarketBeat
UK: QuidelOrtho aquires LEX Diagnostics from TTP Group for US$100m - Investors in Healthcare
Finanzdaten der Quidelortho Corp-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Quidelortho Corp-Aktie (QDEL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
0.41%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):